These results suggested that sPD1-p24fc/EP vaccination effectively eliminated three times of AB1-GAG malignant mesothelioma challenges, resulting in the establishment of a vaccine-mediated tumor destruction model. The gene discussed is HOXD13; the disease is malignant mesothelioma.